相似文献
1
Interferon alfa treatment for Sjogren's syndrome associated neuropathy.
J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):576-8. doi: 10.1136/jnnp.2004.049502.
2
Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjögren's syndrome.
Mod Rheumatol. 2009;19(4):437-40. doi: 10.1007/s10165-009-0180-2. Epub 2009 May 22.
3
Acute sensory neuronopathy as the presenting symptom of Sjögren's syndrome.
J Clin Neurosci. 2006 Oct;13(8):862-5. doi: 10.1016/j.jocn.2005.12.029. Epub 2006 Aug 28.
4
The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy.
Brain. 2005 Nov;128(Pt 11):2518-34. doi: 10.1093/brain/awh605. Epub 2005 Jul 27.
5
[Primary Sjögren's syndrome revealing cerebellar syndrome].
Rev Neurol (Paris). 2015 Sep;171(8-9):674-6. doi: 10.1016/j.neurol.2015.03.009. Epub 2015 Apr 22.
6
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome.
Ann Rheum Dis. 2013 May;72(5):782-3. doi: 10.1136/annrheumdis-2012-202754. Epub 2012 Dec 21.
7
Acquired factor VIII inhibitor in Sjögren's syndrome.
Arthritis Care Res (Hoboken). 2010 Jul;62(7):1047-50. doi: 10.1002/acr.20147.
8
D-penicillamine treatment for chronic sensory ataxic neuropathy associated with Sjögren's syndrome.
Neurology. 1998 Nov;51(5):1451-3. doi: 10.1212/wnl.51.5.1451.
9
Diabetes mellitus and renal tubular acidosis in primary Sjögren's syndrome.
J Assoc Physicians India. 2010 Jul;58:451-3.
10
[Sjogren's syndrome-associated neuropathy].
Brain Nerve. 2013 Nov;65(11):1333-42.
引用本文的文献
1
Associations between Sjogren syndrome and psychiatric disorders in European populations: a 2-sample bidirectional Mendelian randomization study.
Front Psychiatry. 2024 Oct 16;15:1465381. doi: 10.3389/fpsyt.2024.1465381. eCollection 2024.
2
Neurological manifestations of primary Sjögren's syndrome.
Reumatologia. 2018;56(2):99-105. doi: 10.5114/reum.2018.75521. Epub 2018 May 9.
3
Safety, Tolerability, and Immunogenicity of Interferons.
Pharmaceuticals (Basel). 2010 Apr 20;3(4):1162-1186. doi: 10.3390/ph3041162.
4
Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.
Neurotherapeutics. 2016 Jan;13(1):163-78. doi: 10.1007/s13311-015-0393-3.
5
Interferons in Sjögren's Syndrome: Genes, Mechanisms, and Effects.
Front Immunol. 2013 Sep 20;4:290. doi: 10.3389/fimmu.2013.00290.
6
Neurological Disorders in Primary Sjögren's Syndrome.
Autoimmune Dis. 2012;2012:645967. doi: 10.1155/2012/645967. Epub 2012 Mar 5.
7
[Indications and options of new immune modulatory therapies for Sjögren's syndrome].
Z Rheumatol. 2007 Dec;66(8):679-85. doi: 10.1007/s00393-007-0231-z.
8
Notes on the kidney and its diseases for the neurologist.
J Neurol Neurosurg Psychiatry. 2007 May;78(5):444-9. doi: 10.1136/jnnp.2006.091991.
9
Inflammatory neuropathies: an update on evaluation and treatment.
Curr Rheumatol Rep. 2005 Oct;7(5):348-55. doi: 10.1007/s11926-005-0019-6.
Zotero 插件